Trevi Therapeutics, Inc.
TRVI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12 | -$12 | -$10 | -$11 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | -$0 | $1 | -$4 | $1 |
| Other Non-Cash | -$0 | -$0 | -$0 | -$0 |
| Operating Cash Flow | -$11 | -$10 | -$13 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$72 | -$17 | -$28 | -$45 |
| Inv. Sales/Matur. | $21 | $14 | $18 | $21 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$51 | -$3 | -$10 | -$24 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | -$0 |
| Stock Issued | $0 | $110 | $0 | $51 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $0 | $9 | $0 |
| Financing Cash Flow | $2 | $110 | $9 | $51 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$60 | $98 | -$15 | $18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $117 | $19 | $34 | $16 |
| End Cash | $57 | $117 | $19 | $34 |
| Free Cash Flow | -$11 | -$10 | -$13 | -$10 |